Compass Pathways PLCNASDAQ:CMPS
- LAST PRICE8.4800
- TODAY'S CHANGE (%)-0.0900 (-1.0502%)
- Bid / Lots8.0100/ 4
- Ask / Lots8.9700/ 1
- Open / Previous Close8.5000 / 8.5700
- Day Range
- 52 Week Range
- Volume282,629
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CMPS |
|---|---|---|
| 09:32 ET | 4169 | 8.475 |
| 09:34 ET | 2860 | 8.6 |
| 09:36 ET | 300 | 8.625 |
| 09:38 ET | 2094 | 8.65 |
| 09:39 ET | 750 | 8.6864 |
| 09:41 ET | 100 | 8.6887 |
| 09:45 ET | 11449 | 8.74 |
| 09:48 ET | 569 | 8.7604 |
| 09:50 ET | 2550 | 8.8286 |
| 09:52 ET | 4323 | 8.8445 |
| 09:54 ET | 1365 | 8.75 |
| 09:56 ET | 5775 | 8.68 |
| 09:57 ET | 4326 | 8.59 |
| 09:59 ET | 200 | 8.52 |
| 10:01 ET | 216 | 8.5899 |
| 10:03 ET | 250 | 8.5532 |
| 10:06 ET | 15984 | 8.535 |
| 10:08 ET | 1268 | 8.5831 |
| 10:12 ET | 1981 | 8.55 |
| 10:14 ET | 750 | 8.512 |
| 10:19 ET | 100 | 8.55 |
| 10:21 ET | 2511 | 8.56 |
| 10:24 ET | 245 | 8.5463 |
| 10:26 ET | 200 | 8.59 |
| 10:28 ET | 1317 | 8.5416 |
| 10:30 ET | 1346 | 8.5 |
| 10:32 ET | 1200 | 8.4531 |
| 10:35 ET | 594 | 8.4313 |
| 10:37 ET | 490 | 8.4731 |
| 10:39 ET | 288 | 8.4269 |
| 10:42 ET | 492 | 8.44 |
| 10:44 ET | 100 | 8.44 |
| 10:46 ET | 2082 | 8.47 |
| 10:50 ET | 300 | 8.43 |
| 10:53 ET | 882 | 8.435 |
| 10:55 ET | 2117 | 8.48 |
| 10:57 ET | 200 | 8.45 |
| 11:00 ET | 200 | 8.45 |
| 11:04 ET | 100 | 8.44 |
| 11:08 ET | 400 | 8.4447 |
| 11:09 ET | 301 | 8.44 |
| 11:11 ET | 200 | 8.435 |
| 11:13 ET | 300 | 8.41 |
| 11:15 ET | 3205 | 8.36 |
| 11:18 ET | 100 | 8.42 |
| 11:20 ET | 900 | 8.35 |
| 11:22 ET | 206 | 8.363 |
| 11:24 ET | 500 | 8.38 |
| 11:33 ET | 200 | 8.405 |
| 11:38 ET | 1200 | 8.405 |
| 11:44 ET | 2756 | 8.45 |
| 11:45 ET | 100 | 8.46 |
| 11:47 ET | 400 | 8.49 |
| 11:49 ET | 600 | 8.46 |
| 11:51 ET | 100 | 8.49 |
| 11:54 ET | 817 | 8.4899 |
| 11:56 ET | 600 | 8.43 |
| 12:02 ET | 1426 | 8.39 |
| 12:05 ET | 570 | 8.38 |
| 12:07 ET | 608 | 8.4162 |
| 12:09 ET | 903 | 8.42 |
| 12:12 ET | 350 | 8.44 |
| 12:14 ET | 200 | 8.43 |
| 12:16 ET | 1290 | 8.45 |
| 12:20 ET | 1500 | 8.455 |
| 12:21 ET | 100 | 8.455 |
| 12:25 ET | 7700 | 8.455 |
| 12:27 ET | 200 | 8.48 |
| 12:30 ET | 100 | 8.46 |
| 12:32 ET | 100 | 8.48 |
| 12:34 ET | 402 | 8.48 |
| 12:36 ET | 200 | 8.48 |
| 12:38 ET | 2400 | 8.46 |
| 12:41 ET | 500 | 8.43 |
| 12:48 ET | 150 | 8.42 |
| 12:50 ET | 100 | 8.42 |
| 12:52 ET | 740 | 8.4 |
| 12:54 ET | 500 | 8.35 |
| 12:56 ET | 474 | 8.3383 |
| 12:57 ET | 100 | 8.325 |
| 12:59 ET | 300 | 8.36 |
| 01:01 ET | 1117 | 8.365 |
| 01:03 ET | 100 | 8.3593 |
| 01:06 ET | 1053 | 8.35 |
| 01:14 ET | 120 | 8.3692 |
| 01:17 ET | 1500 | 8.3301 |
| 01:19 ET | 911 | 8.365 |
| 01:28 ET | 434 | 8.3526 |
| 01:33 ET | 1897 | 8.36 |
| 01:35 ET | 825 | 8.375 |
| 01:37 ET | 200 | 8.38 |
| 01:42 ET | 100 | 8.36 |
| 01:46 ET | 200 | 8.37 |
| 01:48 ET | 334 | 8.4 |
| 01:55 ET | 100 | 8.4 |
| 02:00 ET | 740 | 8.4 |
| 02:02 ET | 100 | 8.34 |
| 02:04 ET | 706 | 8.41 |
| 02:06 ET | 900 | 8.45 |
| 02:08 ET | 500 | 8.45 |
| 02:09 ET | 100 | 8.44 |
| 02:15 ET | 200 | 8.46 |
| 02:18 ET | 100 | 8.46 |
| 02:20 ET | 200 | 8.46 |
| 02:22 ET | 100 | 8.46 |
| 02:24 ET | 2168 | 8.47 |
| 02:29 ET | 2770 | 8.53 |
| 02:31 ET | 997 | 8.5 |
| 02:33 ET | 500 | 8.46 |
| 02:36 ET | 608 | 8.51 |
| 02:38 ET | 621 | 8.5529 |
| 02:40 ET | 1451 | 8.62 |
| 02:42 ET | 250 | 8.62 |
| 02:44 ET | 300 | 8.66 |
| 02:45 ET | 600 | 8.59 |
| 02:47 ET | 100 | 8.66 |
| 02:49 ET | 800 | 8.66 |
| 02:51 ET | 200 | 8.59 |
| 02:54 ET | 5168 | 8.7 |
| 02:56 ET | 725 | 8.71 |
| 02:58 ET | 1750 | 8.65 |
| 03:00 ET | 17127 | 8.59 |
| 03:02 ET | 440 | 8.7294 |
| 03:03 ET | 1722 | 8.74 |
| 03:05 ET | 2109 | 8.79 |
| 03:07 ET | 795 | 8.84 |
| 03:09 ET | 500 | 8.83 |
| 03:12 ET | 1016 | 8.81 |
| 03:14 ET | 5369 | 8.805 |
| 03:16 ET | 723 | 8.79 |
| 03:18 ET | 700 | 8.74 |
| 03:20 ET | 800 | 8.6801 |
| 03:21 ET | 1438 | 8.71 |
| 03:23 ET | 200 | 8.65 |
| 03:25 ET | 2266 | 8.74 |
| 03:27 ET | 200 | 8.73 |
| 03:30 ET | 3805 | 8.71 |
| 03:32 ET | 1300 | 8.69 |
| 03:34 ET | 2400 | 8.71 |
| 03:36 ET | 720 | 8.68 |
| 03:38 ET | 100 | 8.68 |
| 03:39 ET | 1508 | 8.58 |
| 03:41 ET | 2583 | 8.6209 |
| 03:43 ET | 650 | 8.61 |
| 03:45 ET | 741 | 8.62 |
| 03:48 ET | 2564 | 8.6478 |
| 03:50 ET | 4635 | 8.59 |
| 03:52 ET | 766 | 8.56 |
| 03:54 ET | 4103 | 8.54 |
| 03:56 ET | 2603 | 8.555 |
| 03:57 ET | 3425 | 8.53 |
| 03:59 ET | 3411 | 8.48 |
Apr 29, 2024
Compass Pathways and Journey Clinical establish research collaboration agreement to inform the training of healthcare providers and delivery model for COMP360 psilocybin treatment, if approved for treatment-resistant depression, from 6:30AM ET on Monday Apr 29, 2024 by Dow Jones
6:30AM ET on Monday Apr 29, 2024 by Dow Jones
Apr 1, 2024
DJ Compass Pathways Initiated at Overweight by Morgan Stanley, from 6:59AM ET on Monday Apr 01, 2024 by Dow Jones
6:59AM ET on Monday Apr 01, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Compass Pathways PLC | 585.7M | -3.6x | --- |
Prime Medicine Inc | 590.1M | -2.4x | --- |
Oric Pharmaceuticals Inc | 595.3M | -4.7x | --- |
Oculis Holding AG | 544.4M | 0.0x | --- |
Aerovate Therapeutics Inc | 575.0M | -7.3x | --- |
GH Research PLC | 570.2M | -17.5x | --- |
Company Information
Compass Pathways plc is a United Kingdom-based biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. The Company is engaged in the development of psilocybin treatment, in which its investigational COMP360 psilocybin is administered in conjunction with psychological support, COMP360 psilocybin treatment. COMP360 is its proprietary psilocybin formulation that includes its pharmaceutical-grade polymorphic crystalline psilocybin, optimized for stability and purity. The Company’s initial focus is on treatment-resistant depression (TRD), comprising patients who are inadequately served by the current treatment paradigm. It commenced its Phase III program evaluating its COMP360 psilocybin treatment in TRD. In addition, the Company has ongoing Phase II trials in PTSD and anorexia nervosa. It also provides support to research institutions conducting investigator-initiated studies with COMP360 psilocybin in areas of serious unmet need.
Contact Information
- Headquarters
- 3Rd Floor, 1 Ashley RoadALTRINCHAM, United Kingdom WA14 2DT
- Phone
- ---
- Fax
- ---
Executives
- Interim Independent Chairman of the Board
- David Norton
- Chief Executive Officer, Executive Director
- Kabir Nath
- Chief Financial Officer, Principal Accounting Officer
- Teri Loxam
- General Counsel, Chief Legal Officer
- Matthew Owens
- Chief Medical Officer
- Guy Goodwin
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $585.7M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 68.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.40 |
EPS | $-2.39 |
Book Value | $3.64 |
P/E Ratio | -3.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
